We encountered two afibrinogenemia patients with homozygous and compound heterozygous FGA mutation. Of interest, the patients' parents who are heterozygous, had normal levels of plasma fibrinogen; thus, we hypothesized that liver FGA mRNA levels were higher than those of FGB and/or FGG mRNA. Materials and Methods: To examine the hypothesis, we quantitated mRNA levels of a normal liver and human hepatocyte cell line, HepG2 cells, and performed siRNA-mediated down-regulation of the fibrinogen gene in HepG2 cells. mRNA levels were determined using real-time quantitative RT-PCR for three normal livers and HepG2 cells. Down-regulation of FGA, FGB, or FGG in HepG2 cells was performed by the addition of siRNA corresponding to each of the three genes, and the mRNA levels determined in the cells and the secreted fibrinogen concentration in media. Results: mRNA level of normal human liver was FGA = FGB > FGG and FGG mRNA level was about 2-fold lower than the others, that of HepG2 cells was FGA > FGG > FGB and FGA mRNA was approximately 2-or 4-fold higher than FGG mRNA and FGB mRNA. When FGA, FGB, or FGG mRNA expression levels were down-regulated by nearby 50%, fibrinogen concentrations in media were 78 %, 49 %, or 57 % of control, respectively.
Introduction
Fibrinogen is a 340 kDa plasma glycoprotein composed of two sets of three different polypeptide chains (A, B and  and expressed as (A, B, ) 2 . Each chain is synthesized, assembled into a six-chain molecule in hepatocytes, secreted into the blood, and circulated at 1.8-3.5 g/l [1, 2] . A, B and  chains in plasma fibrinogen are composed of 610, 461 and 411 residues, which comprise 3 genes coding for fibrinogen alpha (FGA), fibrinogen beta (FGB), and fibrinogen gamma (FGG), clustered in a region of approximately 50 kb on chromosome 4q31.3. The 3 genes contain the following numbers of exons: 6 (included A-E isoform) for FGA, 8 for FGB and 10 for FGG [3] [4] [5] . Genetic mutations in fibrinogen chain genes have been associated with afibrinogenemia, hypofibrinogenemia and dysfibrinogenemia, as listed in the fibrinogen variant database [6] .
Genetic abnormalities and the molecular bases in patients with afibrinogenemia have been found in all three genes and identified as missense, nonsense, or frameshift mutations; splice-site abnormalities; or large deletions [4] [5] [6] [7] [8] [9] . In particular, reports causing large deletions between 1.2 and 15 kb were restricted in FGA [6] . Recently, we identified two afibrinogenemias, caused by homozygous deletion of 1238 bases of the A-chain gene (FGA1238) and compound heterozygous deletion of FGA1238 and FGA c.54+3A>C, examined the molecular basis of the lack of protein, and designated them as Yokkaichi and Kurashiki II, respectively [10] .
Two probands showed homozygous abnormality of FGA but, as in the patients' parents, the fibrinogen activity and antigen were normal in spite of having a heterozygous genetic abnormality. Six families, including our two cases, with FGA1238 have only been found in Far Eastern countries, one in China [11] and five in Japan [10, [12] [13] [14] , and regarding which parents and family members have a heterozygous genetic abnormality, the plasma fibrinogen concentrations were all normal (Table 1 ). According to our observation and the coincident reports, we hypothesize these phenomena as follows. When patients have a genetic mutation in FGA causing large deletion, nonsense, frameshift, or splicing abnormality etc., all of which lead to premature termination and nonsense-mediated mRNA decay (NMD), mRNA levels in heterozygous patients' hepatocytes were reduced by approximately half. Under these conditions, if FGA mRNA was more than two-fold higher than that of FGB and/or FGG mRNA, fibrinogen production (assembly and secretion) in hepatocytes and plasma fibrinogen level was not decreased by around half.
In this study, we transfected short interfering RNA (siRNA) of each fibrinogen gene into a human hepatocyte cell line, HepG2 cells, which produce fibrinogen in culture media. We also compared the associations between mRNA levels of FGA, FGB, or FGG in HepG2 cells and fibrinogen concentration in media. Further, we bibliographically compared the plasma fibrinogen levels of the patients with heterozygous mutations in FGA, FGB, or FGG genes.
Materials and methods

Cell culture
A human hepatocyte cell line, HepG2 cells, was cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS; HyClone Laboratories, Inc., Logan, UT, USA), 50 U/ml penicillin, and 50 g/ml streptomycin (GIBCO) in a 5% CO 2 incubator at 37°C.
Fibrinogen gene expression in normal human liver cells
Total RNA from normal human livers (liver RNA #1: 60-year-old man, liver RNA #2:
64-year-old man, liver RNA #3: 86-year-old man) was purchased from BioChain (Newark, CA, USA). The cDNA was synthesized from 2 g total RNA in 40l reaction buffer and analyzed as described below by real-time quantitative RT-PCR.
siRNA-mediated down-regulation of the fibrinogen gene, FGA, FGB, or FGG, in HepG2 cells
Silencer Select Pre-designed FGA siRNA (catalog no. 4392420, IDs5115), FGB siRNA (ID s5119), FGG siRNA (ID s5179), and Negative Control #1 siRNA (catalog no. 4390843) were obtained from Ambion (Austin, TX, USA). Each siRNA was reversely transfected into HepG2 cells in technical triplicates in 3 independent experiments. Briefly, each siRNA was mixed with 100 μl OPTI-MEM I Reduced Serum Medium (GIBCO) in a 24-well tissue culture plate, and 1 l of Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) was added to each well, mixed gently, and incubated for 20 minutes at room temperature according to the manufacturer's protocol.
Then, 500 l HepG2 cells suspension containing 5 x 10 4 cells was added to the mixture of siRNA reagent. The final concentrations of FGA, FGB, and FGG siRNA varied between 1.0 and 30 nM and negative control siRNA was used at 10 nM, and the absence of siRNA was used as a non-transfected control. To ensure the siRNA effects on fibrinogen production, 6 hours after transfection, medium was removed, and 600l fresh antibiotic-free medium were added to each well. Thirty hours after transfection, culture medium was collected and fibrinogen concentrations determined by enzyme-linked immunosorbent assay (ELISA). HepG2 cells were trypsinized and harvested to perform quantitative analysis of each mRNA. To obtain a nearly 50 % decrease of FGA, FGB, or Real-time quantitative RT-PCR was performed using an ABI PRISM 7900 Sequence
Detection System (Applied Biosystems) at 50 °C for 2 min, 95 °C for 10 min, followed by 50 cycles at 95 °C for 15 s and 60 °C for 1 min. Threshold cycle (Ct) values were obtained using SDS, Version 2.3 software (Applied Biosystems). To determine the relative mRNA levels between target and endogenous reference control mRNA, the comparative Ct (2 -Ct ) method was used. Briefly, the expression of the target gene was calculated as follows: Ct = (Ct target -Ct ABL ) siRNA x -(Ct target -Ct ABL ) siRNA 0 (siRNAx means objective siRNA concentration) [15] .
Validation of the 2 -Ct method
Validation assays for the efficiency of amplification of the target gene (FGA, FGB and FGG) and endogenous reference control gene (ABL) were examined using real-time PCR and TaqMan detection. The cDNA was synthesized from HepG2 cells, and serial dilutions of cDNA were amplified by real-time PCR, as described in Materials and Methods. The average
Ct was calculated for the target gene (Ct target ) and ABL (Ct ABL ), and the Ct (Ct target -Ct ABL ) was determined. The log cDNA dilution was plotted against Ct.
ELISA assay
To determine the fibrinogen concentrations of culture media, ELISA was performed using the following reagents: capture antibody: goat anti-human fibrinogen antibody (Cappel, Durham, NC) (1:1,000 dilution), secondary antibody: goat anti-human fibrinogen antibody (Abcam, Tokyo, Japan) biotinated using Biotin labeling Kit-NH 2 (Dojindo Laboratories, Mashiki-cho, Kumamoto, Japan) (1:40,000 dilution), detection reagents: streptoavidin conjugated horseradish peroxidase (Beckman Coulter, Fullerton, CA, USA) (1:8,000 dilution) and TMB microwell peroxidase substrate system (Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA). Calibration curve for fibrinogen was linear over a concentration range of 20-200 ng/ml and the limit of detection was 5 ng/ml.
Statistical analysis
The data were derived from repeated experiments for each assay and values are expressed as the mean ± SD. Datasets were analyzed using Student's t test and p <0.05 was considered significant.
Results
Fbg mRNA expression for human normal liver and HepG2 cells
Real-time quantitative RT-PCR for fibrinogen mRNA was performed for normal human liver RNA and HepG2 cells, as described in Materials and Methods. Representative amplification curves of mRNA of FGA, FGB, and FGG are shown in Figure 1 . can be used to analyze the data [15] .
siRNA down-regulation of fibrinogen gene on HepG2 cells
To determine the siRNA concentration that could inhibit the mRNA expression level by nearby 50 %, we varied the concentration of each siRNA (between 1.25 and 30.0 nM) added to culture media. Each mRNA level was determined by real-time quantitative RT-PCR, and each fibrinogen concentration in the culture media was determined by ELISA. As shown in 
Discussion
We encountered two afibrinogenemic patients' parents who are heterozygous genetic FGA abnormality and normal levels of plasma fibrinogen [10] . Thus, we hypothesized that in normal liver, FGA mRNA was more than two-fold higher than FGB and/or FGG mRNA, and if FGA mRNA was decreased by almost half by a mutation with FGA mRNA decay, plasma fibrinogen was not decreased and was maintained in the normal range. To examine the hypothesis, we quantitated mRNA levels for three normal livers and a human hepatocyte cell line, HepG2 cells, and performed siRNA-mediated down-regulation of fibrinogen genes, FGA, FGB, and FGG, in HepG2 cells.
Real-time quantitative RT-PCR showed that mRNA level in the normal human liver was FGA = FGB > FGG, and the FGG mRNA level was about 2-fold lower than the others, that of HepG2 cells was FGA > FGG > FGB, and FGA mRNA was approximately 2-or 4-fold higher than FGG mRNA or FGB mRNA. Result obtained from the normal human liver implies that FGG mRNA levels are limiting fibrinogen production in normal liver. We thought that the discordancy in the order of mRNA levels between in the normal human liver less than that of the A and  chains, and the rate was faster in the order A, and B chain [16] . This order coincided with our order of mRNA level. Further, previous studies of fibrinogen synthesis with B-chain cDNA in HepG2 or COS-1 cells have shown that an excess amount of A and  chains accumulated in the cells [16] [17] [18] , suggesting that the synthesis of the B chain is a rate-limiting peptide for the assembly and secretion of mature fibrinogen. We showed plasma fibrinogen concentration for probands with afibrinogenemia causing homozygote FGA1238bp mutation and compound heterozygotes including FGA1238bp mutation, and their heterozygous family members in Table 1 [10] [11] [12] [13] [14] . Plasma fibrinogen levels of all heterozygous individuals were almost normal, and 1 of 16 people had <1.5 g/l by either the functional method or immunological determination method. Further, we showed plasma fibrinogen concentrations of probands with afibrinogenemia and their heterozygous family members in Table 2 [11, [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] . Genetic mutations in Table 2 included nonsense, frameshift, and splicing abnormality in FGA, FGB, or FGG, all of which lead to premature termination and NMD [33, 34] . Normal range of plasma fibrinogen was not standardized world-wide, however, it was generally 1.5 -4.0 or 2.0 -4.0 g/l, as shown in Table 1 and 2 [10] [11] [12] [13] [14] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] . Namely, there is the 2 or 2.7-fold difference between the lower-limit and the Table 1 ).
Down
Of interest, the frequency of plasma fibrinogen <1.5 g/l was 85.7 % for FGA (6/7), 82.4 % for FGB (28/34), and 97.8 % for FGG mutation (45/46). Namely, for genetic mutations which did not lead to lower levels of each mRNA than normal, plasma fibrinogen in people with FGA mutations was lower than the normal range and its frequency was equivalent to people with FGB or FGG mutations. Further, in Table 1 , Our results indicate that FGA mRNA in the normal human liver and HepG2 cells was about 2-fold more than FGG, suggest that 1) FGG mRNA expression level is limiting but FGA mRNA expression level is not in normal liver, 2) when the FGA mRNA expression level in HepG2 cells is decreased by around half, fibrinogen secretion remains approximately 80%, explaining the observation that people with a heterozygous genetic FGA abnormality had normal levels of plasma fibrinogen. Although the FGB mRNA level in normal human liver was almost the same as FGA mRNA (different from the mRNA expression level in HepG2 cells), plasma fibrinogen in people with heterozygous genetic FGB mutations was lower than normal. These observations suggest the presence of regulatory mechanisms that reduce the synthesis of B chain polypeptide from FGB mRNA [35] [36] [37] . In conclusion, we considered that the plasma fibrinogen level might be regulated by the translation level of B and/or  chain.
Finally, presented data suggest that the normal level of plasma fibrinogen in patients with heterozygous FGA mutations, which reduce mRNA, was caused as follows: synthesis of an excess amount of normal A chain mRNA (and peptide) from the normal allele compensates for the reduced level of A chain mRNA (and peptide) from the mutant allele. In addition, our data also imply that latent individuals with heterozygous genetic FGA abnormality might exist much more, because their plasma fibrinogen levels are normal. Fibrinogen concentration <2.0 g/l is shown by underlining and <1.5 g/l is shown by double underlining. Fibrinogen concentration <2.0 g/l is shown by underlining and <1.5 g/l is shown by double underlining.
Supplement Table 1 Cases of hypofibrinogenemic families with heterozygous missense mutations.
ND: Not determined, a: afibrinogenemia, h: hypofibrinogenemia, h/d: hypofibrinogenemia/dysfibrinogenemia Fibrinogen concentration <2.0 g/l is shown by underlining and <1.5 g/l is shown by double underlining. Fibrinogen concentration less than 2.0g/l was showed by underline and less than 1.5g/l showed by double underline.
Figure Legends
Case
No. Mutation
Fibrinogen concentration (g/l) Fibrinogen concentration less than 2.0g/l was showed by underline and less than 1.5g/l showed by double underline.
Case
No. Mutation
Fibrinogen concentration (g/l)
Normal range Reference No.
Propositus and homozygote Heterozygote
Supplement ND: Not determined, a: afibrinogenemia, h: hypofibrinogenemia, h/d: hypofibrinogenemia/dysfibrinogenemia Fibrinogen concentration less than 2.0g/l was showed by underline and less than 1.5g/l showed by double underline. 
